122 related articles for article (PubMed ID: 8866773)
1. How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia.
Barnes TR; McPhillips MA
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():115-21. PubMed ID: 8866773
[TBL] [Abstract][Full Text] [Related]
2. [Neuroleptic induced deficit syndrome].
Szafrański T
Psychiatr Pol; 1995; 29(3):359-69. PubMed ID: 7652089
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
4. [Incidence of the deficit form in refractory schizophrenia].
Samuelian JC
Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
[TBL] [Abstract][Full Text] [Related]
5. Negative symptoms in patients with schizophrenia with special reference to the primary versus secondary distinction.
Fleischhacker W
Encephale; 2000 Oct; 26 Spec No 1():12-4. PubMed ID: 11294057
[TBL] [Abstract][Full Text] [Related]
6. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.
Naber D
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():133-8. PubMed ID: 8866775
[TBL] [Abstract][Full Text] [Related]
7. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
8. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
Nkam I; Langlois-Thery S; Dollfus S; Petit M
Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
[TBL] [Abstract][Full Text] [Related]
9. [Significance of primary negative symptoms in schizophrenic and other psychiatric patients].
Gerbaldo H; Müller-Siecheneder F
Fortschr Neurol Psychiatr; 1996 Jun; 64(6):221-7. PubMed ID: 8766995
[TBL] [Abstract][Full Text] [Related]
10. [Deficit: the value and difficulty of defining the primary or secondary character of observed symptoms].
Petit M; Langlois S
Encephale; 1996 Jun; 22 Spec No 2():13-8. PubMed ID: 8767036
[TBL] [Abstract][Full Text] [Related]
11. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
[TBL] [Abstract][Full Text] [Related]
12. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
Nkam I; Langlois-Thery S; Dollfus S; Petit M
Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
[TBL] [Abstract][Full Text] [Related]
13. Depression in patients with schizophrenia during an acute psychotic episode.
Tapp A; Kilzieh N; Wood AE; Raskind M; Tandon R
Compr Psychiatry; 2001; 42(4):314-8. PubMed ID: 11458306
[TBL] [Abstract][Full Text] [Related]
14. Measurement of negative symptoms in schizophrenia.
de Leon J; Wilson WH; Simpson GM
Psychiatr Dev; 1989; 7(3):211-34. PubMed ID: 2700801
[TBL] [Abstract][Full Text] [Related]
15. Positive family history is associated with persistent elevated emotional distress in schizophrenia: evidence from a 16-month follow-up study.
Ritsner MS; Ratner Y; Gibel A; Weizman R
Psychiatry Res; 2007 Dec; 153(3):217-23. PubMed ID: 17675246
[TBL] [Abstract][Full Text] [Related]
16. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
17. [Methodological constraints in evaluating anti-deficit effects].
Boyer P; Lecrubier Y; Rein W
Encephale; 1996 Jun; 22 Spec No 2():25-7. PubMed ID: 8767038
[TBL] [Abstract][Full Text] [Related]
18. Assessing the effects of atypical antipsychotics on negative symptoms. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():28-34. PubMed ID: 9766617
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance, evaluation, and management of secondary depression in schizophrenia.
Becker RE; Singh MM; Meisler N; Shillcutt S
J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):26-32. PubMed ID: 2865254
[TBL] [Abstract][Full Text] [Related]
20. The relationship between insight and symptoms in schizophrenia.
Sevy S; Nathanson K; Visweswaraiah H; Amador X
Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
